Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion type Assertion NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_head.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion description "[P-cadherin was present in 80 of the 261 breast cancers (31%) and was more frequently present in tumors that have a basal epithelial phenotype [i.e., high-grade, estrogen receptor- and KIP1 (p27(Kip1))-negative tumors, with expression of cytokeratin 5/6, cyclin E, TP53, and presence of BRCA1 mutations and vascular nests (all P < 0.001)].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_provenance.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion evidence source_evidence_literature NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_provenance.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion SIO_000772 15930334 NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_provenance.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion wasDerivedFrom befree-2016 NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_provenance.
- NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_assertion wasGeneratedBy ECO_0000203 NP497560.RAc2hdCnaIGYXoB9Kspjue7j8kkiE6KkZ1UIQ4PKSmLd0130_provenance.